Highlights
FabiFlu registers 600 percent jump in sales for the month of April
FabiFlu has topped the list of drugs with maximum sales value by recording Rs 762 crore sales
New Delhi: Anti-viral drug FabiFlu, which is used in treating COVID-19, has registered a 600 percent jump in sales for the month of April and is now the largest selling pharma brand in India for the first time.
FabiFlu recorded a whopping sale of Rs 352 crores in the month of April. Before FabiFlu lifestyle ailment drugs for diseases like diabetes dominated the chart.
FabiFlu also is the top-selling COVID-19 drug and has overtaken the health supplement Zincovit and pain killer Dolo.